Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200465 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Ali Mirzaesmaeili und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Kinesiology and Health Science, Muscle Health Research Centre, York University, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Gout, Inflammasomes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: CIHR, Gouvernement du Canada | Canadian Institutes of Health Research, Arthritis Society.
Abstract (Originalsprache)
Secretion of IL-1β, a potent cytokine that plays a key role in gout pathogenesis, is regulated by inflammasomes. TRAF1 has been linked to heightened risk to inflammatory arthritis. In this article, we show that TRAF1 negatively regulates inflammasome activation to limit caspase-1 and IL-1β secretion in human and mouse macrophages. TRAF1 reduces linear ubiquitination and subsequent oligomerization of the adapter protein, ASC. i.p. injection of monosodium urate crystals resulted in increased inflammatory cell infiltrates and IL-1β production in Traf1 knockout mice compared with wild type littermates. In a model of monosodium urate crystal–induced gout, Traf1 knockout mice exhibited more swelling in the knee joints, increased infiltration of inflammatory cells, and higher expression of proinflammatory cytokines. In summary, this study identifies TRAF1 as a key regulator of IL-1β production and a potential therapeutic target for inflammasome-driven diseases such as gout.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Kinesiology and Health Science, Muscle Health Research Centre, York University, Toronto, Ontario, Canada.
- Spondylitis Program, Division of Rheumatology, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada; and.
- Department of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Ali Mirzaesmaeili, Jonathan Raspanti, Ali Akram, Robert D Inman, Ali A Abdul-Sater
Förderung
- CIHR
- Gouvernement du Canada | Canadian Institutes of Health Research
- Arthritis Society
Zitieren
APA
Mirzaesmaeili, A., Zangiabadi, S., Raspanti, J., Akram, A., Inman, R. D., & Abdul-Sater, A. A. (2023). Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200465
Vancouver
Mirzaesmaeili A, Zangiabadi S, Raspanti J, Akram A, Inman RD, Abdul-Sater AA. Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200465
BibTeX
@article{Mirzaesmaeili2023,
author = {Mirzaesmaeili, Ali and Zangiabadi, Safoura and Raspanti, Jonathan and Akram, Ali and Inman, Robert D and Abdul-Sater, Ali A},
title = {Cutting Edge: Negative Regulation of Inflammasome Activation by TRAF1 Can Limit Gout},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200465}
}
EUVIMED